Indicators of chymase-positive MCs in the lungs of patients with COVID-19 are presented in statistically significantly lower numbers than in controls, while the content of CPA3-positive MCs and their degranulation activity are higher in patients with COVID-19. This evidence concerns the gene CMA1 and COVID-19.